0001209191-13-053098.txt : 20131119 0001209191-13-053098.hdr.sgml : 20131119 20131119162831 ACCESSION NUMBER: 0001209191-13-053098 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131025 FILED AS OF DATE: 20131119 DATE AS OF CHANGE: 20131119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mack David Henry CENTRAL INDEX KEY: 0001341642 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 131230291 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2013-10-25 2013-10-25 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001341642 Mack David Henry ONE EMBARCADERO CENTER, 37TH FLOOR SAN FRANCISCO CA 94111 1 0 0 0 Option (right to buy) 3.15 2023-09-12 Common Stock 28000 D This option was granted on September 12, 2013. The option is exercisable as follows: on or after the 12th day of each successive month beginning October 12, 2013, the option may be exercised to purchase up to an additional 1/36th of the number of option shares. Reflects a one-for-five reverse stock split of the Issuer's common stock effected October 8, 2013. David Mack 2013-11-19